Trials / Completed
CompletedNCT00213694
PROSTACOX : Metastatic Prostate Chemotherapy
Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (planned)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.
Detailed description
Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | docetaxel and celecoxib |
Timeline
- Start date
- 2003-11-01
- Completion
- 2006-06-01
- First posted
- 2005-09-21
- Last updated
- 2013-03-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00213694. Inclusion in this directory is not an endorsement.